​
Login / Signup
Navin Rajapakse
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 2
Top Topics
Wild Type
Induced Apoptosis
Mesenchymal Stem Cells
Highly Efficient
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Kyle Begovich
,
Angela Schoolmeesters
,
Navin Rajapakse
,
Elena Martinez-Terroba
,
Maneesh Kumar
,
Arvind Shakya
,
Chon Lai
,
Steven Greene
,
Brandon Whitefield
,
Akinori Okano
,
Venkat Mali
,
Shenlin Huang
,
Aparajita H Chourasia
,
Leah Fung
Cereblon-based Bifunctional Degrader of SOS1, BTX-6654, Targets Multiple KRAS Mutations and Inhibits Tumor Growth.
Molecular cancer therapeutics
23 (4) (2024)
Kyle Begovich
,
Angela Schoolmeesters
,
Navin Rajapakse
,
Elena Martinez-Terroba
,
Maneesh Kumar
,
Arvind Shakya
,
Chon Lai
,
Steven Greene
,
Brandon Whitefield
,
Akinori Okano
,
Venkat Mali
,
Shenlin Huang
,
Aparajita H Chourasia
,
Leah Fung
Cereblon-Based Bifunctional Degrader of SOS1, BTX-6654, Targets Multiple KRAS Mutations and Inhibits Tumor Growth.
Molecular cancer therapeutics
(2024)